Holen Sie sich die Stockscreener-App
36.70
78.33%
16.12
Vorhandelsmarkt:
37.03
0.33
+0.90%
Schlusskurs vom Vortag:
$20.58
Offen:
$21.25
24-Stunden-Volumen:
4.83M
Relative Volume:
11.51
Marktkapitalisierung:
$751.57M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-75.86M
KGV:
-7.1864
EPS:
-5.1069
Netto-Cashflow:
$-59.39M
1W Leistung:
+75.43%
1M Leistung:
+115.88%
6M Leistung:
+53.69%
1J Leistung:
+194.07%
1-Tages-Spanne:
$21.25
$37.58
1-Wochen-Bereich:
$19.95
$37.58
52-Wochen-Spanne:
$9.10
$37.58
Forte Biosciences Inc Stock (FBRX) Company Profile
Firmenname
Forte Biosciences Inc
Sektor
Branche
Telefon
(310) 618-6994
Adresse
3060 PEGASUS PARK DRIVE, DALLAS, CA
Compare FBRX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
36.70 | 751.57M | 0 | -75.86M | -59.39M | -5.1069 |
VRTX
Vertex Pharmaceuticals Inc
|
496.50 | 126.01B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.95 | 70.03B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
909.49 | 56.56B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
312.79 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
191.13 | 40.63B | 742.00K | -1.37B | -1.07B | -7.0731 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-25 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-18 | Eingeleitet | Guggenheim | Buy |
| 2025-01-21 | Eingeleitet | TD Cowen | Buy |
| 2024-04-08 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | Hochstufung | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Herabstufung | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Herabstufung | Truist | Buy → Hold |
| 2021-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-26 | Eingeleitet | Citigroup | Buy |
| 2020-08-28 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Eingeleitet | Truist | Buy |
Alle ansehen
Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten
Forte Biosciences skin pigmentation disorder drug shows strong efficacy, safety in early study - MSN
FBRX Stock Explodes Higher On Surging Momentum - timothysykes.com
Enovix, Forte Biosciences rally premarket; PepsiCo slips By Investing.com - Investing.com South Africa
Market movers: Forte Biosciences, Micron Technology, Simply Good Foods, PepsiCo… - Proactive financial news
Forte Biosciences shares surge after positive phase 1b vitiligo results - Yahoo Finance
FBRX Stock On Track For Biggest Single-Day Gains In 20 Months – What’s Behind The Super Rally? - TradingView
Forte Biosciences Skin Pigmentation Disorder Drug Shows Strong Efficacy, Safety In Early Study - Benzinga
Forte Bio surges on trial data for vitiligo drug (FBRX:NASDAQ) - Seeking Alpha
Forte Biosciences Shares Climb After Positive Phase 1b Vitiligo Trial Results (FBRX) - Yahoo Finance
Forte Biosciences’ FB102 Shows Statistically Significant Improvement in Vitiligo in Phase 1b Trial With Strong Safety Profile – Minichart - Minichart
Forte Biosciences Reports Positive Phase 1b Vitiligo Results - TipRanks
Forte Biosciences reports positive phase 1b vitiligo trial results - Investing.com
Forte Biosciences stock jumps on positive vitiligo trial data - Investing.com
Forte Biosciences reports positive Phase 1b vitiligo data for FB102 with 29.6% mean FVASI improvement - TradingView
[8-K] Forte Biosciences, Inc. Reports Material Event - Stock Titan
Forte’s skin-disease drug showed measured gains through week 24 - Stock Titan
Federated Hermes (FBRX) shows 2.11M-share, 10.31% Schedule 13G/A stake - Stock Titan
Certain Options of Forte Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 8-JUL-2026. - marketscreener.com
Forte Biosciences Inc focuses on dermatology pipeline as investors weigh long-term prospects - AD HOC NEWS
FRTX to Acquire Crinetics Pharmaceuticals for $10 Billion - GuruFocus
RSU vesting boosts holdings at Forte Biosciences (NASDAQ: FBRX) - Stock Titan
FBRXForte Biosciences Inc Options - Finviz
(FBRX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Enterprise value to EBIT forward of Forte Biosciences, Inc. – NASDAQ:FBRX - TradingView
Forte Biosciences, Inc.(NasdaqCM:FBRX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 2500 Growth Benchmark - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 2000 Index - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM:FBRX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 2000 Growth Benchmark - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 3000E Growth Benchmark - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell Small Cap Completeness Index - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) dropped from Russell 3000E Value Benchmark - marketscreener.com
FBRX Q1 2026 Earnings: EPS Misses Estimates, No Revenue Reported, Stock Gains 2.15%Earnings Deceleration Risk - dars.gov.et
Forte Biosciences Inc (FBRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Forte Biosciences Inc (FBRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Forte Biosciences Inc (FBRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Forte Biosciences Inc (FBRX) Institutional Confidence - TradingKey
Forte Biosciences Inc (FBRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Forte Biosciences (FBRX) CFO receives 22,000 stock options grant - Stock Titan
Forte Biosciences (FBRX) awards 500,000 stock options to insider Wagner - Stock Titan
Forte Biosciences Inc (FBRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Forte Biosciences Inc (FBRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Forte Biosciences Inc (FBRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Forte Biosciences (FBRX) Dips Nearly 5%: Testing Key Support at $16.29Revenue Weighted - newsline.com
One Forte Biosciences Insider Raised Stake By 30% In Previous Year - Yahoo Finance
[EFFECT] Forte Biosciences, Inc. SEC Filing - Stock Titan
FBRX Q1 2026 Earnings: Wider-than-Expected Loss as Biotech Continues DevelopmentMargin Guidance - newsline.com
Trading Systems Reacting to (FBRX) Volatility - Stock Traders Daily
Forte Biosciences (FBRX) Gains 5%: Support and Resistance Levels in FocusWave Extension - dars.gov.et
Millennium Group (FBRX) reports shared control of 1,062,182 shares - Stock Titan
Forte Biosciences | S-3/A: Registration statement for specified transactions by certain issuers (Amendment) - Moomoo
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.48%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):